Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Managed care allergy survey

This article was originally published in The Tan Sheet

Executive Summary

Forty-eight percent of managed care organizations "promote or have educational programs to utilize [Schering-Plough's] Claritin (OTC) over Clarinex (Rx)," according to survey conducted by The New England Consulting Group on "the draconian steps being taken to reduce pharmaceutical costs." Data compiled from responses of 41 major MCOs also indicates 78% of health plans have "promoted or educated...members on OTC allergy alternatives to Clarinex, [Aventis'] Allegra and [Pfizer's] Zyrtec"...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS095502

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel